medigraphic.com

2003, Number 3

<< Back Next >>

Rev Fac Med UNAM 2003; 46 (3)

Viability of mycoplasms in front of different antibiotics

Rivera TJA, Romero AO, Santellan OMR, Román MC

Language: Spanish
References: 12
Page: 97-100
PDF size: 40.34 Kb.


ABSTRACT

Medical importance of mycoplasmas is related with various illnesses such as joint, respiratory and urogenital tract diseases. It has even been considered as cofactor of the acquired immunodeficiency syndrome (AIDS). Viability of mycoplasma was studied in various culture media with different antibiotics that do not interfere with its metabolism and facilitate its isolation. Mycoplasma fermentans in presence of vancomycin, gentamycin, bacitracin, ceftriaxone, netilmycin and amykacin shows a slow metabolism, in comparison with other mycoplasmas. Mycoplasma penetrans, Mycoplasma pirum, Mycoplasma hominis and Mycoplasma pneumoniae presented growth at 24 hours in presence of these antibiotics.


REFERENCES

  1. Razin S, Yogev D, Naot Y. Molecular biology and pathogenicity of mycoplasmas. Microbiol Mol Biol Rev 1998; 62: 1094-156.

  2. Tully JG. Current status of the Mollicutes flora of humans. Clin Infec Dis 1993; 17 (Suppl 1): 2-9.

  3. Duffy LB, Crabb D, Searcey K, Kempf MC. Comparative potency of gemifloxacin, new quinolones, macrolides, tetracycline and clindamycin against Mycoplasma spp. J Antimicrob Chemother 2000; 45 (Suppl 1): 29-33.

  4. Cassell GH, Waites KB, Crouse DT. Perinatal mycoplasmal infections. Clin Perinatol 1991; 18: 241-62.

  5. Cassell GH, Davies JK, Waites KB, et al. Pathogenesis and significance of urogenital mycoplasmal infections. Adv Exp Med Biol 1987; 224: 93-115.

  6. Cassell GH, Blanchard A, Duffy L, Crabb D, Waites KB. Mycoplasmas. In: Howard BJ, Keiser JF, Weissfield AS, Smith TF, Tilton RC., (Eds). Clinical and Pathogenic Microbiology. St. Louis, MO. Mosby Year Book 1994: 491-502.

  7. Roberts MC, Koutsky LA, Holmes KK, LeBlanc DJ, Kenny GE. Tetracycline-resistant Mycoplasma hominis strains contain streptococcal tetM sequences. Antimicrob Agents Chemother 1985; 28: 141-3.

  8. Bebear CM, Renaudin H, Charron A, Gruson D, Lefrancois M, Bebear C. In vitro activity of trovafloxacin compared to those of five antimicrobials against mycoplasmas including Mycoplasma hominis and Ureaplasma urealyticum fluorquinolone-resistant isolates that have been genetically characterized. Antimicrob Agents Chemother 2000; 44: 2557-60.

  9. Hannan PC, Woodnutt G. In vitro activity of gemifloxacin (SB 265805; LB20304a) against human mycoplasmas. J Antimicrob Chemother 2000; 45: 367-9.

  10. Hannan PC. Antibiotic susceptibility of Mycoplasma fermentans strains from various sources and the development of resistance to aminoglycoside in vitro. J Med Microbiol 1995; 42: 421-8.

  11. Hayes MM, Wear DJ, Lo SC. In vitro antimicrobial susceptibility testing for the newly identified AIDS-associated Mycoplasma. Mycoplasma fermentans (incognitus strain). Arch Pathol Lab Med 1991; 115: 464-6.

  12. Pereyre S, Gonzalez P, de Barbeyrac B, Darnige A, Renaudin H, Charron A, et al. Mutation in 23S rRNA account for intrinsic resistance to macrolides in Mycoplasma hominis and Mycoplasma fermentans and for acquired resistance to macrolides in M. hominis. Antimicrob Agents Chemother 2002; 46: 3142-50.




2020     |     www.medigraphic.com